Functional outcome of intrathecal baclofen administration for severe spasticity
Authors:
- Efstathios J. BoviatsisEBEfstathios J. Boviatsis
- Andreas T. KouyialisAKAndreas T. Kouyialis
- Stefanos KorfiasSKStefanos Korfias
- Damianos E. SakasDSDamianos E. Sakas
- 30 June 2005
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 107 (4) , 289-295
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticityJournal of Neurosurgery, 2002
- Intrathecal Baclofen for Intractable Cerebral Spasticity: A Prospective Placebo-controlled, Double-blind StudyNeurosurgery, 2000
- Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticityJournal of Neurosurgery, 1996
- Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-upArchives of Physical Medicine and Rehabilitation, 1996
- Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter studyJournal of Neurosurgery, 1993
- A Pilot StudyThe Clinical Journal of Pain, 1992
- Intrathecal Baclofen for Severe Spinal SpasticityNew England Journal of Medicine, 1989